Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|January 1, 1989
Combination chemotherapy of cisplatin and 5-fluorouracil for advanced colorectal adenocarcinomaN J Petrelli, S Madejewicz, Y Rustum, et al.
Seminars in Oncology|December 1, 1996
Early phase studies with paclitaxel/low-dose carboplatin in patients with solid tumorsP J Creaven, D Raghavan, R P Perez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Phase I/pharmacodynamic study of N-acetylcysteine/oltipraz in smokers: early termination due to excessive toxicityL Pendyala, G Schwartz, W Bolanowska-Higdon, et al.
Cancer Chemotherapy Reports|July 1, 1975
Phase I clinical trial of isophosphamide (NSC-109724)M H Cohen, P J Creaven, F Tejada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancerN Soni, N J Meropol, L Pendyala, et al.
Cancer Research|October 1, 1984
Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancerS Madajewicz, N Petrelli, Y M Rustum, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I clinical trial of 1-(2-[2-(4-pyridyl)-2-imidazoline-1-yl]-ethyl)-3-(4-carboxy-phenyl) urea (CGP 15720A)P J Creaven, S Madajewicz, L Pendyala, et al.
Cancer Treatment Reports|January 1, 1982
Phase I trial and pharmacokinetics of a daily x 5 schedule of 3-deazauridineP J Creaven, R L Priore, A Mittelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathioneL Pendyala, P J Creaven, G Schwartz, et al.
Pageof 12